In T2D, the patient is unable to process insulin signaling correctly, making the body insulin-resistant, which is the inability of cells to respond adequately to normal levels of insulin within the liver, muscle, and fat tissues. This evidence concerns the gene INS and type 2 diabetes mellitus.